FutureLife brings Alife AI to 60 European IVF clinics in 2026
May 5, 2026
FutureLife and Alife Health announced a Europe-wide AI fertility platform on May 5, 2026. The rollout covers 60 clinics in 16 countries.
FutureLife scales AI support in reproductive medicine
FutureLife Group announced a network-wide partnership with Alife Health on May 5, 2026. The aim is a comprehensive AI platform for fertility care across 60 clinics in 16 countries. FutureLife cites more than 77,000 IVF cycles per year and more than 2,400 specialists.
Embryo Predict supports embryo assessment
The central tool is Embryo Predict, Alife's CE-marked AI product. It supports assessment of blastocysts for transfer decisions and, according to the announcement, generates an AI score and patient-friendly reports. The CE mark under the EU Medical Device Regulation was received in October 2025.
The platform covers more than one step
The partnership also includes Success Predictor and Egg Retrieval Report. These tools are intended to provide additional information before and during treatment. The important limit: they do not replace doctors or embryologists; they provide decision support in a tightly clinical process.
A Europe-wide rollout follows a pilot phase
FutureLife refers to a successful multi-clinic pilot followed by expansion across the full network. That matters because many medical AI projects remain stuck in pilots. This announcement is about institutional adoption across borders.
Why it matters
Medical AI is judged especially carefully because mistakes can affect patients directly. At the same time, fertility care is data-heavy, emotionally difficult and expensive. Standardized, documented AI support could make workflows more comparable, but it must remain transparently validated and clinically supervised.
A practical example
An IVF clinic in Prague runs 1,500 cycles per year. Embryologists still use microscopy, experience and lab values, but also receive an AI score and a report for patient discussions. The final transfer decision stays with the clinical team. For the clinic, the value would mainly be consistency across sites, not automatic decision-making.
💡 In plain English
The AI helps clinics organize information in fertility treatment. It gives hints, but doctors still make the decisions.
Key Takeaways
- →FutureLife announced the partnership on May 5, 2026.
- →The rollout covers 60 clinics in 16 countries.
- →FutureLife cites more than 77,000 IVF cycles annually.
- →Embryo Predict received CE marking under EU MDR in October 2025 according to the announcement.